JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.6% |
| 2 | Financials | 12.17% |
| 3 | Healthcare | 9.21% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Industrials | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
PUT
Lumen
LUMN
$6.6B
| $186K | ﹤0.01% |
16,000
| – | – |
|
4502
Cerus
CERS
$572M
| $185K | ﹤0.01% |
37,415
-9,923
| -21% | -$54.9K |
|
4503
Esquire Financial Holdings
ESQ
$1.59B
| $184K | ﹤0.01% |
7,404
-58
| -0.8% | -$1.37K |
|
|
STKL
4504
DELISTED
SunOpta
STKL
| $184K | ﹤0.01% |
57,621
+22,498
| +64% | +$83K |
|
|
ISEE
4505
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $184K | ﹤0.01% |
152,320
+149
| +0.1% | +$204 |
|
4506
Galmed Pharmaceuticals
GLMD
$4.39M
| $183K | ﹤0.01% |
163
-42
| -20% | -$54.2K |
|
4507
NRC Health Common Stock
NRC
$471M
| $183K | ﹤0.01% |
3,304
-84
| -2% | -$3.89K |
|
4508
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
| $182K | ﹤0.01% |
1,856
+178
| +11% | +$17.3K |
|
4509
Ultrapar
UGP
$6.55B
| $182K | ﹤0.01% |
34,282
-9,396
| -22% | -$51K |
|
4510
PLDT
PHI
$4.2B
| $181K | ﹤0.01% |
7,140
-117,997
| -94% | -$2.8M |
|
|
PAMT
4511
PAMT Corp
PAMT
$285M
| $181K | ﹤0.01% |
12,348
-1,756
| -12% | -$23.9K |
|
|
AFT
4512
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $180K | ﹤0.01% |
12,090
| – | – |
|
|
GARS
4513
DELISTED
Garrison Capital Inc.
GARS
| $180K | ﹤0.01% |
26,075
+2,400
| +10% | +$16.8K |
|
4514
CryoPort
CYRX
$766M
| $179K | ﹤0.01% |
9,970
+3,334
| +50% | +$52.9K |
|
4515
Capital City Bank Group
CCBG
$898M
| $178K | ﹤0.01% |
7,189
+46
| +0.6% | +$1.08K |
|
4516
Greenlane Holdings
GNLN
$1.22M
| – | – |
0
| – | – |
|
|
CHUY
4517
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $178K | ﹤0.01% |
7,747
+1,375
| +22% | +$29.6K |
|
4518
SmartFinancial
SMBK
$899M
| $177K | ﹤0.01% |
8,271
+5,462
| +194% | +$113K |
|
|
ATAXZ
4519
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $177K | ﹤0.01% |
24,876
+4,652
| +23% | +$33.1K |
|
|
HIL
4520
DELISTED
Hill International, Inc. Common Stock
HIL
| $176K | ﹤0.01% |
65,179
+25,069
| +63% | +$66.2K |
|
4521
Origin Bancorp
OBK
$1.69B
| $175K | ﹤0.01% |
5,309
+1,048
| +25% | +$35.6K |
|
4522
Willis Lease Finance
WLFC
$1.15B
| $175K | ﹤0.01% |
9,480
-1,005
| -10% | -$17K |
|
4523
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
| $174K | ﹤0.01% |
2,974
-6,460
| -68% | -$372K |
|
4524
PUT
G-III Apparel Group
GIII
$1.43B
| $174K | ﹤0.01% |
+6,100
| New | +$208K |
|
4525
ACNB Corp
ACNB
$660M
| $173K | ﹤0.01% |
4,736
-262
| -5% | -$9.82K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.